Literature DB >> 31264264

Сlass II histone deacetylases in the post-stroke recovery period-expression, cellular, and subcellular localization-promising targets for neuroprotection.

Svetlana Demyanenko1, Elena Berezhnaya1, Maria Neginskaya1, Stanislav Rodkin1, Valentina Dzreyan1, Maria Pitinova1.   

Abstract

Histone deacetylases (HDAC) inhibitors can protect nerve cells after a stroke, but it is unclear which HDAC isoform is involved in this effect. We studied cellular and intracellular rearrangement of class II HDACs at late periods after photothrombotic infarct (PTI) in the mouse sensorimotor cortex in the tissue surrounding the ischemia core and in the corresponding region of the contralateral hemisphere. We observed a decrease in HDAC4 in cortical neurons and an increase in its nuclear translocation. HDAC6 expression in neurons was also increased. Moreover, HDAC6-positive cells had elevated apoptosis. Tubostatin A (Tub A)-induced decrease in the activity of HDAC6 restored acetylation of α-tubulin during the early poststroke recovery period and reduced apoptosis of nerve cells thus protecting the brain tissue. Selective inhibition of HDAC6 elevated expression of growth-associated protein-43 (GAP43), which remained high up to 14 days after stroke and promoted axogenesis and recovery from the PTI-induced neurological deficit. Selective HDAC6 inhibitor Tub A markedly reduced neuronal death and increased acetylation of α-tubulin and the level of GAP43. Thus, HDAC6 inhibition could be a promising strategy for modulation of brain recovery as it can increase the intensity and reduce the duration of reparation processes in the brain after stroke.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  HDAC6; Tubastatin A; brain regeneration; class II histone deacetylases; cortex; photothrombotic infarction; stroke

Year:  2019        PMID: 31264264     DOI: 10.1002/jcb.29266

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

Review 1.  The Roles of Histone Modifications in Metal-Induced Neurological Disorders.

Authors:  Yingying Wu; Ruike Wang; Rundong Liu; Yue Ba; Hui Huang
Journal:  Biol Trace Elem Res       Date:  2022-02-07       Impact factor: 3.738

Review 2.  Epigenetic mechanisms and potential therapeutic targets in stroke.

Authors:  Kahlilia C Morris-Blanco; Anil K Chokkalla; Vijay Arruri; Soomin Jeong; Samantha M Probelsky; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2022-07-19       Impact factor: 6.960

Review 3.  Histone Deacetylases as Epigenetic Targets for Treating Parkinson's Disease.

Authors:  Yan Li; Zhicheng Gu; Shuxian Lin; Lei Chen; Valentina Dzreyan; Moez Eid; Svetlana Demyanenko; Bin He
Journal:  Brain Sci       Date:  2022-05-21

4.  Expression of Histone Deacetylases HDAC1 and HDAC2 and Their Role in Apoptosis in the Penumbra Induced by Photothrombotic Stroke.

Authors:  S V Demyanenko; V A Dzreyan; M A Neginskaya; A B Uzdensky
Journal:  Mol Neurobiol       Date:  2019-09-06       Impact factor: 5.590

Review 5.  Histone Deacetylase Inhibitors: A Novel Strategy for Neuroprotection and Cardioprotection Following Ischemia/Reperfusion Injury.

Authors:  Zachary Pickell; Aaron M Williams; Hasan B Alam; Cindy H Hsu
Journal:  J Am Heart Assoc       Date:  2020-05-22       Impact factor: 5.501

Review 6.  Updating a Strategy for Histone Deacetylases and Its Inhibitors in the Potential Treatment of Cerebral Ischemic Stroke.

Authors:  Yuzhen Xu; Qian Wang; Jianxin Chen; Yihong Ma; Xueyuan Liu
Journal:  Dis Markers       Date:  2020-09-05       Impact factor: 3.434

7.  Exogenous recombinant Hsp70 mediates neuroprotection after photothrombotic stroke.

Authors:  S Demyanenko; V Nikul; S Rodkin; A Davletshin; M B Evgen'ev; D G Garbuz
Journal:  Cell Stress Chaperones       Date:  2020-09-01       Impact factor: 3.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.